BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 17072976)

  • 1. Identification of specific genes and pathways involved in NSAIDs-induced apoptosis of human colon cancer cells.
    Huang RH; Chai J; Tarnawski AS
    World J Gastroenterol; 2006 Oct; 12(40):6446-52. PubMed ID: 17072976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells.
    Sun Y; Tang XM; Half E; Kuo MT; Sinicrope FA
    Cancer Res; 2002 Nov; 62(21):6323-8. PubMed ID: 12414664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MAPK (ERK2) kinase--a key target for NSAIDs-induced inhibition of gastric cancer cell proliferation and growth.
    Husain SS; Szabo IL; Pai R; Soreghan B; Jones MK; Tarnawski AS
    Life Sci; 2001 Nov; 69(25-26):3045-54. PubMed ID: 11758830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apo2L/TRAIL differentially modulates the apoptotic effects of sulindac and a COX-2 selective non-steroidal anti-inflammatory agent in Bax-deficient cells.
    He Q; Luo X; Huang Y; Sheikh MS
    Oncogene; 2002 Sep; 21(39):6032-40. PubMed ID: 12203115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase-2 (COX-2) inhibitors sensitize tumor cells specifically to death receptor-induced apoptosis independently of COX-2 inhibition.
    Totzke G; Schulze-Osthoff K; Jänicke RU
    Oncogene; 2003 Sep; 22(39):8021-30. PubMed ID: 12970750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of NSAIDs on proliferation of gastric cancer cells in vitro: possible implication of cyclooxygenase-2 in cancer development.
    Sawaoka H; Kawano S; Tsuji S; Tsujii M; Murata H; Hori M
    J Clin Gastroenterol; 1998; 27 Suppl 1():S47-52. PubMed ID: 9872498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression.
    Elder DJ; Halton DE; Hague A; Paraskeva C
    Clin Cancer Res; 1997 Oct; 3(10):1679-83. PubMed ID: 9815550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The COX-2 selective inhibitor-independent COX-2 effect on colon carcinoma cells is associated with the Delta1/Notch1 pathway.
    Zhang H; Ye Y; Bai Z; Wang S
    Dig Dis Sci; 2008 Aug; 53(8):2195-203. PubMed ID: 18320325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclooxygenase (COX) inhibitors induce apoptosis in non-small cell lung cancer through cyclooxygenase independent pathways.
    Sánchez-Alcázar JA; Bradbury DA; Pang L; Knox AJ
    Lung Cancer; 2003 Apr; 40(1):33-44. PubMed ID: 12660005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Par-4, a proapoptotic gene, is regulated by NSAIDs in human colon carcinoma cells.
    Zhang Z; DuBois RN
    Gastroenterology; 2000 Jun; 118(6):1012-7. PubMed ID: 10833474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective cyclooxygenase-2 inhibitors show a differential ability to inhibit proliferation and induce apoptosis of colon adenocarcinoma cells.
    Yamazaki R; Kusunoki N; Matsuzaki T; Hashimoto S; Kawai S
    FEBS Lett; 2002 Nov; 531(2):278-84. PubMed ID: 12417326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anti-apoptotic property of NS-398 at high dose can be mediated in part through NF-kappaB activation, hsp70 induction and a decrease in caspase-3 activity in human osteosarcoma cells.
    Moalic-Juge S; Liagre B; Duval R; Corbiere C; Bianchi A; Bordji K; Bosgiraud C; Beneytout JL
    Int J Oncol; 2002 Jun; 20(6):1255-62. PubMed ID: 12012007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway.
    Yasumaru M; Tsuji S; Tsujii M; Irie T; Komori M; Kimura A; Nishida T; Kakiuchi Y; Kawai N; Murata H; Horimoto M; Sasaki Y; Hayashi N; Kawano S; Hori M
    Cancer Res; 2003 Oct; 63(20):6726-34. PubMed ID: 14583467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific COX-2 inhibitor NS398 induces apoptosis in human liver cancer cell line HepG2 through BCL-2.
    Huang DS; Shen KZ; Wei JF; Liang TB; Zheng SS; Xie HY
    World J Gastroenterol; 2005 Jan; 11(2):204-7. PubMed ID: 15633216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial cytochrome c release and caspase-3-like protease activation during indomethacin-induced apoptosis in rat gastric mucosal cells.
    Fujii Y; Matsura T; Kai M; Matsui H; Kawasaki H; Yamada K
    Proc Soc Exp Biol Med; 2000 Jun; 224(2):102-8. PubMed ID: 10806417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase-2 overexpression inhibits death receptor 5 expression and confers resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human colon cancer cells.
    Tang X; Sun YJ; Half E; Kuo MT; Sinicrope F
    Cancer Res; 2002 Sep; 62(17):4903-8. PubMed ID: 12208739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of differentially expressed genes in human colon carcinoma cells treated with a selective COX-2 inhibitor.
    Zhang Z; DuBois RN
    Oncogene; 2001 Jul; 20(33):4450-6. PubMed ID: 11494140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of selective cyclooxygenase-2 inhibitor NS-398 on 5-fluorouracil chemotherapy and progression of colon cells: an experimental study].
    Zhang YC; Wang S; Zhang H; Ye YJ; Liang B; Cui ZR
    Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):583-6. PubMed ID: 15144595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-steroidal anti-inflammatory drugs protect against chondrocyte apoptotic death.
    Mukherjee P; Rachita C; Aisen PS; Pasinetti GM
    Clin Exp Rheumatol; 2001; 19(1 Suppl 22):S7-11. PubMed ID: 11296547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dihydrotestosterone (DHT) modulates the ability of NSAIDs to induce apoptosis of prostate cancer cells.
    Andrews P; Krygier S; Djakiew D
    Cancer Chemother Pharmacol; 2002 Mar; 49(3):179-86. PubMed ID: 11935209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.